Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoPRIME: Combined Antiplatelet Strategy in Acute Ischemic Stroke
NCT07844603Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Sep 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
A Phase 2 trial of clopidogrel in ischemic stroke, sponsored by University of Alberta. Started Sep 2025; status: completed.
02
Drugs
clopidogrel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07844603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07844603.